Enable JavaScript to visit this website.

Educate

THE GLOBAL mBC VISION 2025 PRELIMINARY CALL-TO-ACTION HELPED FORM THE FOUNDATION OF A GLOBAL CHARTER

First steps to improving metastatic breast cancer (mBC) patient care by 2025

The "Global Status of mBC Decade Report" laid the foundation for a 2016 collaboration with European School of Oncology (ESO) and Pfizer that fostered the development of a preliminary Call-to-Action. Comprised of ten distinct goals, the Call-to-Action is designed to help the fight against breast cancer around the world and improve the lives of people living with mBC.

The preliminary Global mBC Vision 2025 Call-to-Action was developed to address the most pressing, pertinent, and actionable gaps that patients with advanced/mBC face. This Call-to-Action was created by a multi-stakeholder taskforce to ensure that challenges faced by mBC patients rise to the top of the healthcare agenda around the world.

This important work has been advanced by the multi-stakeholder ABC Global Alliance to form the ABC Global Charter. For more information, please click here.

10 Goals Over the Next 10 Years to Drive Global
Improvements in mBC Care

Learn more

A 10-YEAR REVIEW OF mBC

The Global Status of Advanced/Metastatic Breast Cancer 2005-2015 Decade Report analyzed the mBC landscape over the past decade in order to highlight gaps in patient care, access to resources and support, and treatment outcomes for women around the world. This report was developed by Pfizer Oncology, working collaboratively with the European School of Oncology (ESO) under the framework of the International Consensus Conference for Advanced Breast Cancer (ABC).

A steering committee of global multidisciplinary mBC advisors—comprised of physicians, leaders of patient-support organizations, and patients—contributed to the development of this report.